Something Old, Something New: is Praziquantel Enough for Schistosomiasis Control?

References

• World Health Organization . Schistosomiasis: number of people treated in 2011. Wkly Epidemiol. Rec.88 (8), 81–88 (2013).
   PubMedGoogle Scholar
• Rollinson D , KnoppS, LevitzSet al. Time to set the agenda for schistosomiasis elimination. Acta Trop.128 (2), 423–440 (2013).
   PubMed Web of Science ®Google Scholar
• Njenga SM , MutungiFM, WamaeCN, MwanjeMT, NjiruKK, BockarieMJ. Once a year school-based deworming with praziquantel and albendazole combination may not be adequate for control of urogenital schistosomiasis and hookworm infection in Matuga District, Kwale County, Kenya. Parasit. Vectors.7, 74 (2014).
   PubMed Web of Science ®Google Scholar
• Lelo AE , MburuDN, MagomaGNet al. No apparent reduction in schistosome burden or genetic diversity following four years of school-based mass drug administration in Mwea, central Kenya, a heavy transmission area. PLoS Negl. Trop. Dis.8 (10), e3221 (2014).
   PubMed Web of Science ®Google Scholar
• Ross AG , OlvedaRM, ChyDet al. Can mass drug administration lead to the sustainable control of schistosomiasis? J. Infect. Dis. 211 (2), 283–289 (2015).
   PubMed Web of Science ®Google Scholar
• Won KY , AbudhoB, BlackstockAJet al. Assessment of quality of life as a tool for measuring morbidity due to Schistosoma mansoni infection and the impact of treatment. Am. J. Trop. Med. Hyg.90 (2), 322–328 (2014).
   PubMed Web of Science ®Google Scholar
• Omedo MO , MateyEJ, AwitiAet al. Community health workers’ experiences and perspectives on mass drug administration for schistosomiasis control in western Kenya: the SCORE Project. Am. J. Trop. Med. Hyg.87 (6), 1065–1072 (2012).
   PubMed Web of Science ®Google Scholar
• Olliaro P , Delgado-RomeroP, KeiserJ. The little we know about the pharmacokinetics and pharmacodynamics of praziquantel (racemate and R-enantiomer). J. Antimicrob. Chemother.69 (4), 863–870 (2014).
   PubMed Web of Science ®Google Scholar
• Meister I , Ingram-SieberK, CowanNet al. Activity of praziquantel enantiomers and main metabolites against Schistosoma mansoni. Antimicrob. Agents. Chemother.58 (9), 5466–5472 (2014).
   PubMed Web of Science ®Google Scholar
• Valentim CL , CioliD, ChevalierFDet al. Genetic and molecular basis of drug resistance and species-specific drug action in schistosome parasites. Science342 (6164), 1385–1389 (2013).
   PubMed Web of Science ®Google Scholar
• Guglielmo S , CorteseD, VotteroFet al. New praziquantel derivatives containing NO-donor furoxans and related furazans as active agents against Schistosoma mansoni. Eur. J. Med. Chem.84, 135–145 (2014).
   PubMed Web of Science ®Google Scholar
• Secor WE . Water-based interventions for schistosomiasis control. Pathog. Glob. Health108 (5), 246–254 (2014).
   PubMed Web of Science ®Google Scholar
• Keiser J , SiluéKD, AdiossanLKet al. Praziquantel, mefloquine-praziquantel, and mefloquine-artesunate-praziquantel against Schistosoma haematobium: a randomized, exploratory, open-label trial. PLoS Negl. Trop. Dis.8 (7), e2975 (2014).
   PubMed Web of Science ®Google Scholar
• King CH , OlbrychSK, SoonM, SingerME, CarterJ, ColleyDG. Utility of repeated praziquantel dosing in the treatment of schistosomiasis in high-risk communities in Africa: a systematic review. PLoS Negl. Trop. Dis.5 (9), e1321 (2011).
   PubMed Web of Science ®Google Scholar
• Tukahebwa EM , VennervaldBJ, NuwahaF, KabatereineNB, MagnussenP. Comparative efficacy of one versus two doses of praziquantel on cure rate of Schistosoma mansoni infection and re-infection in Mayuge District, Uganda. Trans. R. Soc. Trop. Med. Hyg.107 (6), 397–404 (2013).
   PubMed Web of Science ®Google Scholar
• Garba A , LamineMS, BarkiréNet al. Efficacy and safety of two closely spaced doses of praziquantel against Schistosoma haematobium and S. mansoni and re-infection patterns in school-aged children in Niger. Acta Trop.128 (2), 334–344 (2013).
   PubMed Web of Science ®Google Scholar
• Ndeffo Mbah ML , GilbertJA, GalvaniAP. Evaluating the potential impact of mass praziquantel administration for HIV prevention in Schistosoma haematobium high-risk communities. Epidemics7, 22–27 (2014).
   PubMed Web of Science ®Google Scholar
• Ndeffo Mbah ML , SkripL, GreenhalghS, HotezP, GalvaniAP. Impact of Schistosoma mansoni on malaria transmission in Sub-Saharan Africa. PLoS Negl. Trop. Dis.8 (10), e3234 (2014).
   PubMed Web of Science ®Google Scholar
• Knopp S , MohammedKA, AliSMet al. Study and implementation of urogenital schistosomiasis elimination in Zanzibar (Unguja and Pemba islands) using an integrated multidisciplinary approach. BMC Public Health12, 930 (2012).
   PubMed Web of Science ®Google Scholar
• What influences open defecation and latrine ownership in rural households: findings from a global review. www.wsp.org
   Google Scholar